NCT00092170View on ClinicalTrials.gov

An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)

PHASE2CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions

InfectionsPelvic Infections

Interventions

DRUG

MK0826, ertapenem sodium

DRUG

Comparator: Ticarcillin/Clavulanate

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00092170 - An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038) | Biotech Hunter | Biotech Hunter